Condition: Myelodysplastic Syndromes · Sponsor: Gruppo Italiano Malattie EMatologiche dell'Adulto
This is a biological study for adult MDS patients who undergo HSCT procedure. Viable bone marrow samples will be collected and cryopreserved from MDS patients before transplantation and at clinical disease recurrence. CD34+ blast cells at disease relapse after HSCT will be compared with CD34+ cells collected before transplant to study genomic and transcriptomic changes.
This description comes directly from the study's public registry record.
Paola Fazi · 0670390528 · p.fazi@gimema.it
Enrico Crea · 0670390514 · e.crea@gimema.it
Always discuss trial participation with your own doctor first.
| Aou Consorziale Policlinico - Bari - Uo Ematologia Con Trapianto | Bari, Italy | Recruiting |
| Unità di Ricerca e di Malattie del sangue - Ematologia S. Luca Vecchio | Florence, Italy | Recruiting |
| AOU San Martino-IST-Ematologia 1 | Genova, Italy | Recruiting |
| Sezione di Ematologia - Ospedale S.Maria della Misericordia | Perugia, Italy | Recruiting |
| Dip. di Medicina Trasl. E di Precisione - U.O.C. Ematologia | Roma, Italy | Recruiting |
| Policlinico Tor Vergata | Roma, Italy | Recruiting |
| Ististuto Clinico Humanitas - Rozzano - Uo Oncologia Medica Ed Ematologia | Rozzano, Italy | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT04587856